Stem cell-based therapies for multiple sclerosis: Recent advances in animal models and human clinical trials

Regenerative Medicine

Volumn 9, Issue 2, 2014, Pages 129-132

  Lutz, Sarah E ^a   Lengfeld, Justin ^a   Agalliu, Dritan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood brain barrier; experimental autoimmune encephalomyelitis; hematopoietic stem cells; mesenchymal stem cells; multiple sclerosis; neural stem cells; stem cell transplantation

Indexed keywords

ABLATION THERAPY; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL HOMING; CELL POPULATION; CELLULAR IMMUNITY; CHRONIC DISEASE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGENERATIVE MEDICINE; REMYELINIZATION; REVIEW; SYMPTOM; T LYMPHOCYTE; THERAPY EFFECT; TISSUE REGENERATION; TISSUE REPAIR; TRAUMATIC BRAIN INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MYELIN SHEATH; PATHOLOGY; STEM CELL TRANSPLANTATION; TRENDS;

ANIMALS; BLOOD-BRAIN BARRIER; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; STEM CELL TRANSPLANTATION;

EID: 84899057306     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.14.1     Document Type: Review

References (16)

1. Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-Appearing white matter in multiple sclerosis. Brain Pathol. 12, 154-169 (2002)
2. Bogoslovsky T, Chaudhry A, Latour L et al. Endothelial progenitor cells correlate with lesion volume and growth in acute stroke. Neurology 75, 2059-2062 (2010)
3. Huang XT, Zhang YQ, Li SJ et al. Intracerebroventricular transplantation of ex vivo expanded endothelial colony-forming cells restores blood-brain barrier integrity and promotes angiogenesis of mice with traumatic brain injury. J. Neurotrauma 30(24), 2080-2088 (2013)
4. Bogoslovsky T, Spatz M, Chaudhry A et al. Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients. J. Transl. Med. 9, 145 (2011)
5. Menge T, Zhao Y, Zhao J et al. Mesenchymal stem cells regulate blood-brain barrier integrity through TIMP3 release after traumatic brain injury. Sci. Transl. Med. 4, 161ra150 (2012)
6. Pati S, Khakoo AY, Zhao J et al. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev. 20, 89-101 (2011)
7. Darlington PJ, Touil T, Doucet JS et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol. 73, 341-354 (2013)
8. Bai L, Lennon DP, Caplan AI et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat. Neurosci. 15, 862-870 (2012)
9. Bai L, Hecker J, Kerstetter A, Miller RH. Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis. Neurosci. Bull. 29, 239-250 (2013)
10. Darlington PJ, Boivin MN, Bar-Or A. Harnessing the therapeutic potential of mesenchymal stem cells in multiple sclerosis. Expert Rev. Neurother. 11, 1295-1303 (2011)
11. Rafei M, Berchiche YA, Birman E et al. An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis. J. Immunol. 183, 1759-1766 (2009)
12. Abrahamsson SV, Angelini DF, Dubinsky AN et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-Associated invariant T cells in multiple sclerosis. Brain 136, 2888-2903 (2013)
13. Payne NL, Sun G, Herszfeld D et al. Comparative study on the therapeutic potential of neurally differentiated stem cells in a mouse model of multiple sclerosis. PLoS ONE 7, e35093 (2012)
14. Krumbholz M, Theil D, Cepok S et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129, 200-211 (2006
15. Liu KK, Dorovini-Zis K. Regulation of CXCL12 and CXCR4 expression by human brain endothelial cells and their role in CD4+ and CD8+ T cell adhesion and transendothelial migration. J. Neuroimmunol. 215, 49-64 (2009
16. Imitola J, Raddassi K, Park KI et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc. Natl Acad. Sci. USA 101, 18117-18122 (2004